Chronic Obstructive Pulmonary Disease (COPD) Treatment Market 2022 By Emerging Trends, Industry Share, Regional Overview and SWOT Analysis till 2031

In terms of drug class, the combination therapy segment of the chronic obstructive pulmonary disease treatment market held a major share of the global COPD treatment market in 2018. It is likely to maintain its dominance in the chronic obstructive pulmonary disease treatment market during the forecast period, owing to its increased efficacy for COPD treatment. Based on distribution channel, the retail pharmacies segment of the COPD treatment market is estimated to account for a major share of the market. This segment of the chronic obstructive pulmonary disease treatment market is anticipated to expand at a rapid pace during the forecast period, owing to an increase in the number of COPD therapeutics being dispensed through retail pharmacies, and rise in the number of retail pharmacies in developing countries. Chronic obstructive pulmonary disease is characterized by progressive airflow limitation not fully reversible, and is a major cause of morbidity and mortality, worldwide. However, patent expiry of branded products and availability of generic equivalents and alternative treatment options are factors that are expected to hamper the growth of the global COPD treatment market during the forecast period.

Access Full Report @ https://www.transparencymarketresearch.com/chronic-obstructive-pulmonary-disease-copd-treatment-market.html

Global Chronic Obstructive Pulmonary Disease Treatment Market: Prominent Regions

North America held a major share of the global chronic obstructive pulmonary disease treatment market. The COPD treatment market in the region is primarily driven by factors such as highly structured healthcare industry and availability of well-defined reimbursement policies from private and public health insurance firms. In addition, extensive research and development to provide advanced and efficient products, and a large number of players in the region, are factors driving the chronic obstructive pulmonary disease treatment market in North America. The chronic obstructive pulmonary disease market in Asia Pacific is estimated to witness significant growth. Asia Pacific is a relatively untapped COPD treatment market as compared to developed regions. Hence, the region offers immense growth opportunities to market players. Factors such as high prevalence of chronic obstructive pulmonary disease, rise in geriatric population, surge in patient population, and growth of the healthcare industry are fueling the expansion of the COPD treatment market in the region.

Europe held the second-largest share of the global chronic obstructive pulmonary disease treatment market in 2018. Well-developed healthcare infrastructure and increase in the number of incidences of chronic obstructive pulmonary disease are driving the COPD treatment market in the region. The chronic obstructive pulmonary disease treatment markets in the Middle East & Africa and Latin America are projected to witness moderate growth in the near future.

Get a sample of the report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=73763

Chronic Obstructive Pulmonary Disease Treatment Market: Key Players

Key players are expanding their footprint to strengthen their position in the global chronic obstructive pulmonary disease treatment market. Emerging economies, due to increase in the number of patient population, and rise in tobacco smoking and air population, offer lucrative opportunities to key players to increase their market share. Manufacturers are engaging in new product development, collaborations, acquisitions, and distribution agreements. For instance, in July 2018, Orion Corporation signed a multi-year licensing agreement with Menarini to distribute and commercialize the former's Easyhaler products. According to the agreement, Menarini would be supplying Orion's products in Asia Pacific countries such as China, the Philippines, Malaysia, Hong Kong, Indonesia, Vietnam, Thailand, Singapore, South Korea, and Taiwan.

Prominent players operating in the global chronic obstructive pulmonary disease treatment market are AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Novartis AG, Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals Inc. (Sumitomo Dainippon Pharma Co., Ltd.), CHIESI Farmaceutici S.p.A., Orion Corporation, and Mylan N.V.

Request For Custom Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=73763

Chronic Obstructive Pulmonary Disease Treatment Market: Segmentation

COPD Treatment Market by Drug Class

Combination Therapy
Long Acting Muscarinic Antagonist & Inhaled Corticosteroids (LAMA-ICS)
Long Acting Beta Agonist & Inhaled Corticosteroids (LABA-ICS)
Triple Therapy
Others
Corticosteroids
Phosphodiesterase Type 4 Inhibitors
Mucokinetics
Bronchodilators
Long Acting Beta Agonist (LABA)
Short Acting Beta Agonist (SABA)
Long Acting Muscarinic Antagonist (LAMA)
Others
Make an Enquiry before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=73763

COPD Treatment Market by Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
More Related Reports by Transparency Market Research -

Hemostasis Diagnostic Analyzers and Reagents Market:

https://www.transparencymarketresearch.com/hemostasis-diagnostic-analyzers-reagents-market.html

Fragile X Syndrome Market: https://www.transparencymarketresearch.com/fragile-x-syndrome-market.html

Transthyretin Amyloidosis Treatment Market: https://www.transparencymarketresearch.com/transthyretin-amyloidosis-treatment-market.html

Chemotherapy Drugs Market: https://www.transparencymarketresearch.com/chemotherapy-drugs-market.html

Acquired Hemophilia Therapeutics Market: https://www.transparencymarketresearch.com/acquired-hemophilia-therapeutics-market.html

Pulmonary Edema Therapeutics Market: https://www.transparencymarketresearch.com/pulmonary-edema-therapeutics-market.html

Cell Therapy Products Market: https://www.transparencymarketresearch.com/cell-therapy-products-market.html

Veterinary Dermatology Drugs Market: https://www.transparencymarketresearch.com/veterinary-dermatology-drugs-market.html

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

This release was published on openPR.